Adverse Reactions to the Intravesical Administration of Doxorubicin Hydrochloride: Report of 6 Cases
- 1 September 1986
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 136 (3) , 668-669
- https://doi.org/10.1016/s0022-5347(17)45010-5
Abstract
We report 6 cases of adverse systemic reactions to the intravesical instillation of doxorubicin hydrochloride for the treatment of recurrent superficial transitional cell carcinoma of the bladder. Although local reactions to this drug are common they rarely are life-threatening. Significant systemic toxicity has not been reported.Keywords
This publication has 7 references indexed in Scilit:
- Intravesical Instillation of Doxorubicin Hydrochloride and its Incorporation into Bladder TumorsJournal of Urology, 1985
- Intravesical Chemotherapy in a Controlled Trial with Thio-Tepa Versus Doxorubicin HydrochlorideJournal of Urology, 1981
- Intracavitary Doxorubicin Hydrochloride Therapy for Carcinoma in Situ of the BladderJournal of Urology, 1981
- Studies on the Intravesical Action of Topically Administered G 3 H-Doxorubicin Hydrochloride in Men: Plasma Uptake and Tumor PenetrationJournal of Urology, 1980
- Intravesical Therapy with Adriamycin in Patients with Superficial Bladder TumorsEuropean Urology, 1980
- Adriamycin Instillation Therapy for Bladder TumorsThe Tohoku Journal of Experimental Medicine, 1979
- Topical Instillation of Doxorubicin Hydrochloride in the Treatment of Recurring Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1977